Dr. Rongpeng Li distinguished professor in Key Laboratory of Biotechnology for Medicinal Plants of Jiangsu Province, Jiangsu Normal University. He completed post doc in 2012 from Nanjing Tech University, China in Biotechnology and Pharmaceutical Engineering and in 2014 from University of North Dakota in Infection and Immunity.

His research interests include Develop novel therapeutic strategies (e.g., antimicrobial compounds, natural products, and gene delivery) and vaccines (e.g., attenuated bacterial strains) that target to our newly identified signal pathways in cancer or infection diseases using new nano-particles in diagnostics, imaging, and therapy.